Over the last 4 quarters, Novonesis (Novozymes) B has averaged an EPS surprise of 0.16% and a revenue surprise of 0.02%.
Analyze the earnings history of Novonesis (Novozymes) B using advanced sorting and filters.
The chart below shows Novonesis (Novozymes) B's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-02-01 | $0.36 | $0.44 | -18.2 % |
| Q3 | 2023-10-26 | $0.49 | $0.42 | 16.7 % |
| Q2 | 2023-08-09 | $0.32 | $0.42 | -23.8 % |
| Q1 | 2023-04-26 | $0.41 | $0.44 | -6.82 % |
The chart below shows Novonesis (Novozymes) B's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| FY | 2026-02-25 | $4.16B | $4.90B | -15.1 % |
| Q4 | 2024-02-01 | $664.23M | $674.70M | -1.55 % |
| Q3 | 2023-10-26 | $650.51M | $634.28M | 2.56 % |
| Q2 | 2023-08-09 | $616.52M | $632.02M | -2.45 % |
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 25, 2026 for FY.
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 25, 2026 for FY and the Actual EPS was $1.73, which beat the estimate of $0.00.
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 25, 2026 for FY and the Actual Revenue was $4.16B, which missed the estimate of $4.90B.